Where Next with Therapy in Advanced Neuroblastoma?

Overview

Journal Br J Cancer

Specialty Oncology

Date 1990 Mar 1

PMID 2183870

Citations 3

Authors

C R Pinkerton

Affiliations

Soon will be listed here.

Citing Articles

The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell....

Heinze A, Grebe B, Bremm M, Huenecke S, Munir T, Graafen L Front Immunol. 2019; 10:2816.

PMID: 31849984 PMC: 6901699. DOI: 10.3389/fimmu.2019.02816.

The radiation dose-rate effect in two human neuroblastoma cell lines.

Holmes A, McMILLAN T, Peacock J, STEEL G Br J Cancer. 1990; 62(5):791-5.

PMID: 2245172 PMC: 1971544. DOI: 10.1038/bjc.1990.381.

Trends in survival for childhood cancer in Britain diagnosed 1971-85.

Stiller C, Bunch K Br J Cancer. 1990; 62(5):806-15.

PMID: 2173943 PMC: 1971530. DOI: 10.1038/bjc.1990.383.

References

Kushner B, Helson L . Coordinated use of sequentially escalated cyclophosphamide and cell-cycle-specific chemotherapy (N4SE protocol) for advanced neuroblastoma: experience with 100 patients. J Clin Oncol. 1987; 5(11):1746-51. DOI: 10.1200/JCO.1987.5.11.1746. View

Gore M, Calvert A, Smith L . High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation study. Eur J Cancer Clin Oncol. 1987; 23(9):1391-7. DOI: 10.1016/0277-5379(87)90125-8. View

Draper G . Screening for neuroblastoma. BMJ. 1988; 297(6642):152-3. PMC: 1834256. DOI: 10.1136/bmj.297.6642.152. View

Kellie S, de Kraker J, Lilleyman J, Bowman A, Pritchard J . Ifosfamide in previously untreated disseminated neuroblastoma. Results of Study 3A of the European Neuroblastoma Study Group. Eur J Cancer Clin Oncol. 1988; 24(5):903-8. DOI: 10.1016/0277-5379(88)90200-3. View

Brodeur G, Seeger R, Barrett A, Berthold F, Castleberry R, DAngio G . International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol. 1988; 6(12):1874-81. DOI: 10.1200/JCO.1988.6.12.1874. View

Ho A, Thaler J, Willemze R, Lauria F, DeRossi G, Kuse R . Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms. Bone Marrow Transplant. 1989; 4 Suppl 1:60-2. View

Pinkerton C, Lewis I, Pearson A, Stevens M, Barnes J . Carboplatin or cisplatin?. Lancet. 1989; 2(8655):161. DOI: 10.1016/s0140-6736(89)90217-1. View

de Kraker J, Pritchard J, Hartmann O, NINANE J . Single-agent ifosfamide in patients with recurrent neuroblastoma (ENSG study 2). European Neuroblastoma Study Group. Pediatr Hematol Oncol. 1987; 4(2):101-4. DOI: 10.3109/08880018709141255. View

Hill B . Neuroblastoma--an overview of laboratory studies aimed at inducing tumor regression by initiation of differentiation or administration of antitumor drugs. Pediatr Hematol Oncol. 1986; 3(1):73-88. DOI: 10.3109/08880018609031203. View

10.

NINANE J, Pritchard J, MALPAS J . Chemotherapy of advanced neuroblastoma: does adriamycin contribute?. Arch Dis Child. 1981; 56(7):544-8. PMC: 1627345. DOI: 10.1136/adc.56.7.544. View

11.

Hayes F, Green A, Casper J, Cornet J, Evans W . Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity. Cancer. 1981; 48(8):1715-8. DOI: 10.1002/1097-0142(19811015)48:8<1715::aid-cncr2820480805>3.0.co;2-y. View

12.

McElwain T, Hedley D, Gordon M, Jarman M, Millar J, Pritchard J . High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma. Exp Hematol. 1979; 7 Suppl 5:360-71. View

13.

August C, Serota F, Koch P, Burkey E, Schlesinger H, ELKINS W . Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. J Clin Oncol. 1984; 2(6):609-16. DOI: 10.1200/JCO.1984.2.6.609. View

14.

Shafford E, Rogers D, Pritchard J . Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26. J Clin Oncol. 1984; 2(7):742-7. DOI: 10.1200/JCO.1984.2.7.742. View

15.

Thiele C, Reynolds C, Israel M . Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature. 1985; 313(6001):404-6. DOI: 10.1038/313404a0. View

16.

Hartmann O, Kalifa C, Benhamou E, Patte C, Flamant F, Jullien C . Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation. Cancer Chemother Pharmacol. 1986; 16(2):165-9. DOI: 10.1007/BF00256169. View

17.

Philip T, Bernard J, Zucker J, Pinkerton R, Lutz P, Bordigoni P . High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age. J Clin Oncol. 1987; 5(2):266-71. DOI: 10.1200/JCO.1987.5.2.266. View

18.

Philip T, Ghalie R, Pinkerton R, Zucker J, Bernard J, Leverger G . A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique. J Clin Oncol. 1987; 5(6):941-50. DOI: 10.1200/JCO.1987.5.6.941. View

19.

Hartmann O, Benhamou E, Beaujean F, Kalifa C, Lejars O, Patte C . Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J Clin Oncol. 1987; 5(8):1205-11. DOI: 10.1200/JCO.1987.5.8.1205. View

20.

Pritchard J, Kiely E, Rogers D, Spitz L, Shafford E, Brereton R . Long-term survival after advanced neuroblastoma. N Engl J Med. 1987; 317(16):1026-7. DOI: 10.1056/NEJM198710153171611. View